サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は慢性腎臓病（CKD）市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは慢性腎臓病（CKD）の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の慢性腎臓病（CKD）市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは慢性腎臓病（CKD）のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に慢性腎臓病（CKD）市場を分類しています。本研究に含まれる主な企業は：AbbVie、Allergan、Amgen、AstraZeneca、Roche、FibroGen、GlaxoSmithKline、Johnson & Johnson、Keryx、Kissei、Pfizer、Sanofi、Teva

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    ACE Inhibitors
    Calcium Channel Blockers
    Beta Blockers
    Others

用途別の市場セグメント：
    Hospitals
    Specialty Clinics

本レポートの詳細内容
世界の慢性腎臓病（CKD）市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、慢性腎臓病（CKD）タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の慢性腎臓病（CKD）収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の慢性腎臓病（CKD）市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、慢性腎臓病（CKD）市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

慢性腎臓病（CKD）のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：慢性腎臓病（CKD）のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：慢性腎臓病（CKD）の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章慢性腎臓病（CKD）企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：慢性腎臓病（CKD）の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：慢性腎臓病（CKD）の主要企業の概要を提供し、製品の説明と仕様、慢性腎臓病（CKD）の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market
The global Chronic Kidney Disease (CKD) market is projected to grow from US$ 91860 million in 2024 to US$ 111810 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.
Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory condition characterized by persistent airflow limitation that makes it difficult to breathe. COPD encompasses a group of diseases, with the most common being emphysema and chronic bronchitis. 
Emphysema involves the destruction of the air sacs in the lungs, while chronic bronchitis is marked by inflammation and narrowing of the airways. Symptoms include shortness of breath, chronic cough, excessive mucus production, wheezing, and tightness in the chest. COPD is often caused by long-term exposure to irritants, such as cigarette smoke, air pollution, and occupational dust or chemicals.
The condition is progressive and can significantly impact an individual's quality of life. In advanced stages, COPD can result in severe respiratory complications and exacerbations, potentially leading to hospitalizations.
Treatment for COPD typically involves a combination of medication, pulmonary rehabilitation, oxygen therapy, and in severe cases, surgical intervention such as lung volume reduction surgery or lung transplantation. Quitting smoking, avoiding lung irritants, and getting vaccinations to prevent respiratory infections are also essential components of COPD management.
COPD is a major public health concern globally, as it can cause significant morbidity and mortality. Early diagnosis, proper management, and lifestyle modifications are critical for maintaining the respiratory function and improving the well-being of individuals living with COPD.
Report Covers:
This report presents an overview of global market for Chronic Kidney Disease (CKD) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Chronic Kidney Disease (CKD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chronic Kidney Disease (CKD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chronic Kidney Disease (CKD) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chronic Kidney Disease (CKD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chronic Kidney Disease (CKD) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc.

Market Segmentation
By Company
    AbbVie
    Allergan
    Amgen
    AstraZeneca
    Roche
    FibroGen
    GlaxoSmithKline
    Johnson & Johnson
    Keryx
    Kissei
    Pfizer
    Sanofi
    Teva

Segment by Type
    ACE Inhibitors
    Calcium Channel Blockers
    Beta Blockers
    Others

Segment by Application
    Hospitals
    Specialty Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chronic Kidney Disease (CKD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Kidney Disease (CKD) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Kidney Disease (CKD) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of ACE Inhibitors
    Table 3. Key Players of Calcium Channel Blockers
    Table 4. Key Players of Beta Blockers
    Table 5. Key Players of Others
    Table 6. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Chronic Kidney Disease (CKD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Chronic Kidney Disease (CKD) Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Chronic Kidney Disease (CKD) Market Share by Region (2019-2024)
    Table 10. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Chronic Kidney Disease (CKD) Market Share by Region (2025-2030)
    Table 12. Chronic Kidney Disease (CKD) Market Trends
    Table 13. Chronic Kidney Disease (CKD) Market Drivers
    Table 14. Chronic Kidney Disease (CKD) Market Challenges
    Table 15. Chronic Kidney Disease (CKD) Market Restraints
    Table 16. Global Chronic Kidney Disease (CKD) Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Chronic Kidney Disease (CKD) Revenue Share by Players (2019-2024)
    Table 18. Global Top Chronic Kidney Disease (CKD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2023)
    Table 19. Global Chronic Kidney Disease (CKD) Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Chronic Kidney Disease (CKD), Headquarters and Area Served
    Table 22. Global Key Players of Chronic Kidney Disease (CKD), Product and Application
    Table 23. Global Key Players of Chronic Kidney Disease (CKD), Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2019-2024)
    Table 27. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2025-2030)
    Table 29. Global Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Chronic Kidney Disease (CKD) Revenue Share by Application (2019-2024)
    Table 31. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Chronic Kidney Disease (CKD) Revenue Share by Application (2025-2030)
    Table 33. North America Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Chronic Kidney Disease (CKD) Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Chronic Kidney Disease (CKD) Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Chronic Kidney Disease (CKD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Chronic Kidney Disease (CKD) Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Chronic Kidney Disease (CKD) Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Chronic Kidney Disease (CKD) Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Chronic Kidney Disease (CKD) Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Chronic Kidney Disease (CKD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Chronic Kidney Disease (CKD) Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Chronic Kidney Disease (CKD) Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Chronic Kidney Disease (CKD) Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Chronic Kidney Disease (CKD) Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Chronic Kidney Disease (CKD) Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Chronic Kidney Disease (CKD) Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Chronic Kidney Disease (CKD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Chronic Kidney Disease (CKD) Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Chronic Kidney Disease (CKD) Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size by Country (2025-2030) & (US$ Million)
    Table 65. AbbVie Company Details
    Table 66. AbbVie Business Overview
    Table 67. AbbVie Chronic Kidney Disease (CKD) Product
    Table 68. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 69. AbbVie Recent Developments
    Table 70. Allergan Company Details
    Table 71. Allergan Business Overview
    Table 72. Allergan Chronic Kidney Disease (CKD) Product
    Table 73. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 74. Allergan Recent Developments
    Table 75. Amgen Company Details
    Table 76. Amgen Business Overview
    Table 77. Amgen Chronic Kidney Disease (CKD) Product
    Table 78. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 79. Amgen Recent Developments
    Table 80. AstraZeneca Company Details
    Table 81. AstraZeneca Business Overview
    Table 82. AstraZeneca Chronic Kidney Disease (CKD) Product
    Table 83. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 84. AstraZeneca Recent Developments
    Table 85. Roche Company Details
    Table 86. Roche Business Overview
    Table 87. Roche Chronic Kidney Disease (CKD) Product
    Table 88. Roche Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 89. Roche Recent Developments
    Table 90. FibroGen Company Details
    Table 91. FibroGen Business Overview
    Table 92. FibroGen Chronic Kidney Disease (CKD) Product
    Table 93. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 94. FibroGen Recent Developments
    Table 95. GlaxoSmithKline Company Details
    Table 96. GlaxoSmithKline Business Overview
    Table 97. GlaxoSmithKline Chronic Kidney Disease (CKD) Product
    Table 98. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 99. GlaxoSmithKline Recent Developments
    Table 100. Johnson & Johnson Company Details
    Table 101. Johnson & Johnson Business Overview
    Table 102. Johnson & Johnson Chronic Kidney Disease (CKD) Product
    Table 103. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 104. Johnson & Johnson Recent Developments
    Table 105. Keryx Company Details
    Table 106. Keryx Business Overview
    Table 107. Keryx Chronic Kidney Disease (CKD) Product
    Table 108. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 109. Keryx Recent Developments
    Table 110. Kissei Company Details
    Table 111. Kissei Business Overview
    Table 112. Kissei Chronic Kidney Disease (CKD) Product
    Table 113. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 114. Kissei Recent Developments
    Table 115. Pfizer Company Details
    Table 116. Pfizer Business Overview
    Table 117. Pfizer Chronic Kidney Disease (CKD) Product
    Table 118. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 119. Pfizer Recent Developments
    Table 120. Sanofi Company Details
    Table 121. Sanofi Business Overview
    Table 122. Sanofi Chronic Kidney Disease (CKD) Product
    Table 123. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 124. Sanofi Recent Developments
    Table 125. Teva Company Details
    Table 126. Teva Business Overview
    Table 127. Teva Chronic Kidney Disease (CKD) Product
    Table 128. Teva Revenue in Chronic Kidney Disease (CKD) Business (2019-2024) & (US$ Million)
    Table 129. Teva Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Chronic Kidney Disease (CKD) Market Share by Type: 2023 VS 2030
    Figure 3. ACE Inhibitors Features
    Figure 4. Calcium Channel Blockers Features
    Figure 5. Beta Blockers Features
    Figure 6. Others Features
    Figure 7. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Chronic Kidney Disease (CKD) Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Specialty Clinics Case Studies
    Figure 11. Chronic Kidney Disease (CKD) Report Years Considered
    Figure 12. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Chronic Kidney Disease (CKD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Chronic Kidney Disease (CKD) Market Share by Region: 2023 VS 2030
    Figure 15. Global Chronic Kidney Disease (CKD) Market Share by Players in 2023
    Figure 16. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2023
    Figure 18. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Chronic Kidney Disease (CKD) Market Share by Type (2019-2030)
    Figure 20. North America Chronic Kidney Disease (CKD) Market Share by Application (2019-2030)
    Figure 21. North America Chronic Kidney Disease (CKD) Market Share by Country (2019-2030)
    Figure 22. United States Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Chronic Kidney Disease (CKD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Chronic Kidney Disease (CKD) Market Share by Type (2019-2030)
    Figure 26. Europe Chronic Kidney Disease (CKD) Market Share by Application (2019-2030)
    Figure 27. Europe Chronic Kidney Disease (CKD) Market Share by Country (2019-2030)
    Figure 28. Germany Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Chronic Kidney Disease (CKD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Chronic Kidney Disease (CKD) Market Share by Type (2019-2030)
    Figure 36. China Chronic Kidney Disease (CKD) Market Share by Application (2019-2030)
    Figure 37. Asia Chronic Kidney Disease (CKD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Chronic Kidney Disease (CKD) Market Share by Type (2019-2030)
    Figure 39. Asia Chronic Kidney Disease (CKD) Market Share by Application (2019-2030)
    Figure 40. Asia Chronic Kidney Disease (CKD) Market Share by Region (2019-2030)
    Figure 41. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Chronic Kidney Disease (CKD) Market Share by Country (2019-2030)
    Figure 51. Brazil Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Chronic Kidney Disease (CKD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. AbbVie Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 58. Allergan Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 59. Amgen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 60. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 62. FibroGen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 63. GlaxoSmithKline Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 65. Keryx Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 66. Kissei Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 68. Sanofi Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 69. Teva Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed